We have experience on both sides of the investment table, working with multi-national corporations looking to license or acquire an asset to build their portfolio, enter a new market, or avoid a patent cliff. On the other side, we have worked with venture backed start-ups searching for, and evaluating, potential partnerships.
Define Strategic Investment Objectives and Evaluate Opportunities
Identify and Analyze L&A Targets
Commercial Due Diligence and Valuation
New or Adjacent Indication Assessment and Prioritization
Deal Module Construction, Evaluation, and Scenario Analysis
A small venture backed pharmaceutical company had an asset in the preclinical development phase and was being approached by multiple potentially interested, significantly larger, companies looking to in-license the drug, or acquire the company and their assets outright.